Shamim Ruff - Net Worth and Insider Trading
Shamim Ruff Net Worth
The estimated net worth of Shamim Ruff is at least $5 Million dollars as of 2024-09-21. Shamim Ruff is the SVP, Regulatory Affairs & Qual of Sarepta Therapeutics Inc and owns about 27,045 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $3 Million. Shamim Ruff is also the Director of Reata Pharmaceuticals Inc and owns about 7,359 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $1 Million. Details can be seen in Shamim Ruff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shamim Ruff has not made any transactions after 2023-07-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shamim Ruff
Shamim Ruff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shamim Ruff owns 2 companies in total, including Sarepta Therapeutics Inc (SRPT) , and Reata Pharmaceuticals Inc (RETA) .
Click here to see the complete history of Shamim Ruff’s form 4 insider trades.
Insider Ownership Summary of Shamim Ruff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2017-11-06 | SVP & Regulatory Affairs & Qual |
| RETA | Reata Pharmaceuticals Inc | 2023-09-26 | director |
Shamim Ruff Latest Holdings Summary
Shamim Ruff currently owns a total of 2 stocks. Among these stocks, Shamim Ruff owns 27,045 shares of Sarepta Therapeutics Inc (SRPT) as of November 6, 2017, with a value of $3 Million and a weighting of 73.06%. Shamim Ruff also owns 7,359 shares of Reata Pharmaceuticals Inc (RETA) as of July 28, 2023, with a value of $1 Million and a weighting of 26.94%.
Latest Holdings of Shamim Ruff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2017-11-06 | 27,045 | 127.17 | 3,439,313 |
| RETA | Reata Pharmaceuticals Inc | 2023-07-28 | 7,359 | 172.36 | 1,268,397 |
Holding Weightings of Shamim Ruff
Shamim Ruff Form 4 Trading Tracker
According to the SEC Form 4 filings, Shamim Ruff has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the sale of 10,000 shares on November 6, 2017, which brought Shamim Ruff around $550,000.
According to the SEC Form 4 filings, Shamim Ruff has made a total of 2 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 8,235 shares on July 28, 2023, which brought Shamim Ruff around $1 Million.
Insider Trading History of Shamim Ruff
- 1
Shamim Ruff Trading Performance
Shamim Ruff Ownership Network
Shamim Ruff Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Shamim Ruff is the SVP & Regulatory Affairs & Qual of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Shamim Ruff made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .
In summary, during the past 3 months, insiders sold 56,699 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net sale of 19,661 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Shamim Ruff Mailing Address
Above is the net worth, insider trading, and ownership report for Shamim Ruff. You might contact Shamim Ruff via mailing address: 215 First Street, Suite 415, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
